3 Top Healthcare Stocks to Buy Now
It's been a good year for healthcare stocks in general, but a handful of quality companies haven't been swept upward with the rest of the sector. Allergan plc (NYSE: AGN) and CVS Health Corp. (NYSE: CVS) are both poised to continue churning out profits and dividends for years to come, but they aren't priced that way. Both have been trading at a much lower multiple of their earnings power and could provide market-beating gains over the long run.
For investors looking for more excitement, Celldex Therapeutics (NASDAQ: CLDX) just passed an important milestone that sets the biotech stock up for a big movement early next year. This tiny company hasn't entered the commercial stage yet, but that could change quickly if its lead candidate can repeat a previous success.
Source: Fool.com
Celldex Therapeutics Aktie
Positive Community-Reaktionen für Celldex Therapeutics mit mehreren Buy-Einschätzungen, keine Sell-Einschätzungen.
Das Community-Kursziel von 62 € für Celldex Therapeutics deutet auf eine deutliche Steigerung um mehr als 50% gegenüber dem aktuellen Kurs von 37.8 € hin.